Insight
The complexities and challenges of getting doctor incentives right
With intense competition for medical talent in the Australian market driven by a shortage of doctors across all specialities and burgeoning healthcare demands, it is absolutely critical for private healthcare providers who rely on doctors’ services - and the financial sponsors who invest in those providers - to structure effective incentives for attracting and retaining doctors.
21 October 2022
Insight
The Asian healthcare revolution – How healthcare markets in Asia are transforming and the opportunities for private capital
From growth capital, to some of the largest global Private Equity (PE)and infrastructure funds, to sovereign wealth funds, private capital of all forms has been increasingly deployed in Asian healthcare assets.
21 October 2022
Insight
Healthcare as an infrastructure investment?
The healthcare industry’s economic resilience – a product of macroeconomic, demographic and industry factors - is attracting ever-increasing amounts of private capital investment and a diverse range of investors with a broader range of strategies and investment mandates.
21 October 2022
Insight
Changing models of care – a snapshot
Hospitals and healthcare systems, both in Australia and around the world, face continued pressure to provide high quality services in a health environment characterised by funding constraints, rapidly rising costs, continuing access inequity, and increasing staff shortages.
21 October 2022
Insight
More widespread reforms for Aged Care – the key changes for investors
Private capital has long been attracted to investment in the aged care sector. Demographic shifts which ensure ever-growing demand, government funding and relative flexibility to invest refundable deposit or accommodation bonds (RADs) over the life of a residency have made it an attractive and stable sector for traditional private equity, infrastructure and real estate investors.
21 October 2022
Publication
Investing in China’s ‘internet hospitals’: twists, turns and why structure matters
Covid provoked a surge worldwide in the use of technology to deliver healthcare services and products.
18 August 2022
Insight
China relaxes rules on lab-developed tests – but uncertainties remain
New regulations in China designed to encourage innovation in clinical trials have made it easier to test human samples in a lab setting.
19 May 2022
